Nurix Therapeutics, Inc. (NRIX)
26.27
-0.45
(-1.68%)
USD |
NASDAQ |
Aug 24, 16:00
26.28
+0.01
(+0.04%)
After-Hours: 20:00
Nurix Therapeutics Total Assets (Quarterly) : 535.54M for May 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2026 | 535.54M |
| February 28, 2026 | 636.13M |
| November 30, 2025 | 702.56M |
| August 31, 2025 | 522.47M |
| May 31, 2025 | 591.56M |
| February 28, 2025 | 615.04M |
| November 30, 2024 | 675.43M |
| August 31, 2024 | 513.60M |
| May 31, 2024 | 511.03M |
| February 29, 2024 | 312.67M |
| November 30, 2023 | 364.54M |
| August 31, 2023 | 308.20M |
| May 31, 2023 | 350.62M |
| February 28, 2023 | 370.15M |
| Date | Value |
|---|---|
| November 30, 2022 | 420.06M |
| August 31, 2022 | 459.34M |
| May 31, 2022 | 394.31M |
| February 28, 2022 | 437.72M |
| November 30, 2021 | 480.10M |
| August 31, 2021 | 493.07M |
| May 31, 2021 | 517.98M |
| February 28, 2021 | 396.66M |
| November 30, 2020 | 396.34M |
| August 31, 2020 | 411.87M |
| May 31, 2020 | 213.28M |
| February 29, 2020 | 88.79M |
| November 30, 2019 | 44.05M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Monte Rosa Therapeutics, Inc. | 691.16M |
| Gilead Sciences, Inc. | 49.36B |
| TG Therapeutics, Inc. | 1.640B |
| Cue Biopharma, Inc. | 30.71M |
| Keros Therapeutics, Inc. | 287.60M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.91M |
| Shareholders Equity (Quarterly) | 402.63M |
| Debt to Equity Ratio | 0.1444 |
| Current Ratio | 6.338 |
| Net Debt Paydown Yield | -0.34% |